Rachel McMinn

NGNE

Rachel McMinn serves as director, officer: Chief Executive Officer at Neurogene Inc. (NGNE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$969.0K

Total Sells

1 trades

$74.0K

Net Position

Net Buyer

$895.0K

Companies Traded

NGNE

Active Period

Nov 2024 – Mar 2026

2 total trades

Most Recent

Sell NGNE

Mar 30, 2026 · $74.0K

Rachel McMinn's Insider Trading at Neurogene Inc. (NGNE)

Buys

1 · $969.0K

Sells

1 · $74.0K

Total Shares Bought

47,500

Total Shares Sold

3,352

NGNE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 30, 2026	Sell	3,352	$22.07	$74.0K	1,344,307
Nov 25, 2024	Buy	47,500	$20.40	$969.0K	1,297,859

Related Insiders

Christine Mikail Cvijic

officer: President and CFO

NGNESell · May 8, 2026

Julie Jordan

officer: Chief Medical Officer

NGNESell · Mar 30, 2026

Stuart Cobb

officer: Chief Scientific Officer

NGNESell · Mar 17, 2026

Explore More Insider Trading Data

NGNE Insider Trading Activity

View all insider trades at Neurogene Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity